tomeko

North Carolina macular dystrophy

Just diagnosed with North Carolina macular dystrophy?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees North Carolina macular dystrophy, look for clinical trials, and connect with others living with it — all in one place.

Open the full North Carolina macular dystrophy hub →

Overview

North Carolina macular dystrophy is a rare condition. Also known as CAPE dystrophy, CAPED, Central areolar pigment epithelial dystrophy, Central retinal pigment epithelial dystrophy, MCDR1, NCMD, North Carolina macular dystrophy, retinal 1, Progressive foveal dystrophy. Tomeko brings together the specialists, research, clinical trials, treatments and community for North Carolina macular dystrophy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:75327 · OMIM 136550, 608850 · ICD-10 H35.5 · GARD 0009179

Find care for North Carolina macular dystrophy

Authoritative references for North Carolina macular dystrophy

Common questions

I was just diagnosed with North Carolina macular dystrophy — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees North Carolina macular dystrophy, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for North Carolina macular dystrophy?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat North Carolina macular dystrophy, filtered to your area.

Are there clinical trials for North Carolina macular dystrophy?

Tomeko shows live, recruiting studies for North Carolina macular dystrophy from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com